GenmabGMAB 
$26.20-0.87%24h
-0.87%24h
Global rank998
Market cap$17.11B
Change 7d-3.50%
YTD Performance-16.43%
SP500 benchmarkUnderperform
P/E3.97
P/S6.97
Revenue$2.45B
Earnings$648.34M
Dividend yield-
Main Sector
Healthcare
Genmab (GMAB) Net Assets
GMAB Net Assets in 2023: $31.61B
As of 18 Nov 2024, Genmab net assets is $31.61B, an increase of 15.86% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Genmab overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Genmab Net Assets History from 2018 to 2024
-
Value:-
GMAB Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $31.61B | 15.86% |
| 2022 | $27.28B | 22.91% |
| 2021 | $22.20B | 16.08% |
| 2020 | $19.12B | 36.11% |
| 2019 | $14.05B | -31844.02% |
| 2018 | $-44.25M | - |
View the Top Net Assets Companies
